ANI PHARMACEUTICALS INC 4

Meredith Cook, Sr. VP, General Counsel & Secretary of ANI Pharmaceuticals Inc., sold 500 shares of common stock at $81.84 per share on July 13, 2026 under a Rule 10b5-1 plan.

On July 13, 2026, Meredith Cook, Sr. VP, General Counsel & Secretary of ANI Pharmaceuticals Inc., sold 500 shares of ANI common stock at an average price of $81.84 per share under a pre-arranged Rule 10b5-1 trading plan adopted on September 15, 2025. The transaction totaled approximately $40,920 and reduced her direct holdings to 77,390 shares of common stock. Based on the transaction price as a proxy for market value, her post-transaction holdings are worth about $6.33 million, indicating she retains a substantial equity position in the company despite this relatively small, pre-planned sale.

Filing Facts

CIK

1023024

Ticker

ANIP

Form

4

Source Type

fda

Accession

0001938861-26-000019

Alert Tier

5